1. Home
  2. CENX vs GNLX Comparison

CENX vs GNLX Comparison

Compare CENX & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Century Aluminum Company

CENX

Century Aluminum Company

HOLD

Current Price

$40.83

Market Cap

2.7B

Sector

Industrials

ML Signal

HOLD

Logo Genelux Corporation

GNLX

Genelux Corporation

HOLD

Current Price

$4.58

Market Cap

202.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CENX
GNLX
Founded
1995
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Aluminum
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
202.4M
IPO Year
1996
2023

Fundamental Metrics

Financial Performance
Metric
CENX
GNLX
Price
$40.83
$4.58
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
4
Target Price
$36.00
$19.75
AVG Volume (30 Days)
1.7M
104.6K
Earning Date
02-19-2026
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.83
N/A
Revenue
$2,525,100,000.00
N/A
Revenue This Year
$15.66
N/A
Revenue Next Year
$0.78
N/A
P/E Ratio
$49.09
N/A
Revenue Growth
20.15
N/A
52 Week Low
$13.05
$1.99
52 Week High
$41.50
$8.54

Technical Indicators

Market Signals
Indicator
CENX
GNLX
Relative Strength Index (RSI) 74.92 47.63
Support Level $38.53 $4.21
Resistance Level $40.83 $4.46
Average True Range (ATR) 1.61 0.24
MACD 0.56 0.08
Stochastic Oscillator 94.58 88.52

Price Performance

Historical Comparison
CENX
GNLX

About CENX Century Aluminum Company

Century Aluminum Co produces primary aluminum standard grade and value-added products. The firm operates smelter facilities in the United States and Iceland. The majority of revenue is generated from Glencore, which agreed to purchase nearly all of Century Aluminum's North American production. Century purchases nearly all of its alumina from Glencore. The company produces high purity aluminum, standard-grade aluminum sow and tee bars, and value-added billet and foundry products. Century also owns a carbon anode production facility in the Netherlands.

About GNLX Genelux Corporation

Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.

Share on Social Networks: